Novel anti-tumour activity of 2,3,5-trimethyl-6-(3-pyridylmethyl)-1,4-benzoquinone (CV-6504) against established murine adenocarcinomas (MAC)

British Journal of Cancer

Volumn 73, Issue 10, 1996, Pages 1187-1192

  Hussey, H J ^a   Bibby, M C ^b   Tisdale, M J ^a  

^a ASTON UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Anti tumour; Lipoxygenase inhibitor; Murine adenocarcinoma; Quinone

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; BENZOQUINONE DERIVATIVE; CYTOTOXIC AGENT; DIHYDROLIPOAMIDE DEHYDROGENASE; HYDROQUINONE; LINOLEIC ACID; LIPOXYGENASE INHIBITOR; SCAVENGER; THROMBOXANE SYNTHASE INHIBITOR;

ADENOCARCINOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CACHEXIA; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADENOCARCINOMA; ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS; BENZOQUINONES; CELL DIVISION; COLONIC NEOPLASMS; GROWTH INHIBITORS; LINOLEIC ACID; LINOLEIC ACIDS; LIPOXYGENASE INHIBITORS; MALE; MICE; MICE, INBRED STRAINS;

EID: 0030015089     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.229     Document Type: Article

References (24)

1. BIBBY MC, DOUBLE JA, ALI SA, FEARON KCH, BRENNAN RA AND TISDALE MJ. (1987). Characterisation of a transplantable adenocarcinoma of the mouse producing cachexia in recipient animals. J. Natl Cancer Inst., 78, 539-546.
2. CHANG , W-C, NING C-C, LIN MT AND HUANG JD. (1992). Epidermal growth factor enhances a microsomal 12-lipoxygenase activity in A431 cells. J. Biol. Chem., 267, 3657-3666.
3. CHEN Y, LIU B, TANG DG AND HONN KV. (1992). Fatty acid modulation of tumor cell - platelet - vessel wall interaction. Cancer Metastasis Rev., 11, 389-410.
4. COLLARD J. (1994). The biochemical mode of action of bioreductive anti-cancer agents. PhD Thesis, University of Bradford.
5. DOUBLE JA, BALL CR AND COWEN PN. (1975). Transplantation of adenocarcinoma of the colon in mice. J. Natl Cancer Inst., 54, 271-275.
6. DOUBLE JA AND BIBBY MC. (1989). Therapeutic index: a vital component in selection of anticancer agents for clinical trial. J. Natl Cancer Inst., 81, 988-994.
7. GLASGOW WC AND ELING TE. (1990). Epidermal growth factor stimulates linoleic acid metabolism in BALB/c 3T3 fibroblasts. Mol. Pharmacol., 38, 503-510.
8. HUDSON EA, BECK SA AND TISDALE MJ. (1993). Kinetics of the inhibition of tumour growth in mice by eicosapentaenoic acid-reversal by linoleic acid. Biochem. Pharmacol., 45, 2189-2194.
9. HUSSEY HJ AND TISDALE MJ. (1994). Effect of polyunsaturated fatty acids on the growth of murine colon adenocarcinomas in vitro and in vivo. Br. J. Cancer, 70, 6-10.
10. ITO K, ABE T, TOMITA M, MORIMOTO A, KOHNO K, MORI T, ONO M, SUGENOYA A, NISHIHIRA T AND KUWANO M. (1993). Anti-angiogenic activity of arachidonic acid metabolism inhibitors in angiogenesis model systems involving human microvascular endothelial cells and neovascularization in mice. Int. J. Cancer, 55, 660-666.
11. LIU B, MARNETT LJ, CHAUDHARY A, JI C, BLAIR IA, JOHNSON CR, DIGLIO CA AND HONN KV. (1994). Biosynthesis of 12(S)-hydroxyeicosatetraenoic acid by B16 amelanotic melanoma cells is a determinant of their metastatic potential. Lab. Invest., 70, 314-323.
12. LYSZ TW, ARORA JK, LIN C AND ZELENKA PS. (1994). 12(S)-Hydroxyeicosatetraenoic acid regulates DNA synthesis and protooncogene expression induced by epidermal growth factor and insulin in rat lens epithelium. Cell Growth Different., 5, 1069-1076.
13. MASFERRER JL, RIMARACHIN JA, GERRITSEN ME, FALCK JR, YADAGIRI P, DUNN MW AND LANIADO-SCHWARTZMAN M. (1991). 12(R)-Hydroxyeicosatrienoic acid, a potent chemotactic and angiogenic factor produced by the cornea. Exp. Eye Res., 52, 417-424.
14. MOSCONI C, AGRADI E, GAMBETTA A, BOZZETTI F AND GALLI C. (1989). Decrease of polyunsaturated fatty acids and elevation of the oleic/stearic acid ratio in plasma and red blood cell lipids of malnourished cancer patients. J. Parent. Ent. Nutr., 13, 501-504.
15. O'BRIEN PJ. (1991). Molecular mechanisms of quinone cytotoxicity. Chem. Biol. Interactions, 80, 1-41.
16. 2 synthase and 5-lipoxygenase with scavenging activity of active oxygen species. Synthesis of a novel series of (3-pyridylmethyl)benzoquinone derivatives. J. Med. Chem., 34, 267-276.
17. OHKAWA S, TERAO T, MURAKAMI M, MATSUMOTO T AND GOTO G. (1991b). Reduction of 2,3,5-Trimethyl-6-(3-pyridylmethyl)-1,4-benzoquinone by PB-3c cells and biological activity of its hydroquinone. Chem. Pharm. Bull., 39, 917-921.
18. PHILLIPS RM, DE LA CRUZ A, TRAVER RD AND GIBSON NW. (1994). Increased activity and expression of NAD(P)H: Quinone acceptor oxidoreductase in confluent cell cultures and within multicellular spheroids. Cancer Res., 54, 3766-3771.
19. POWIS U, GASDASKA PY, GALLEGOS A, SHERRILL K AND GOODMAN D. (1995). Over-expression of DT-diaphorase in transfected NIH 3T3 cells does not lead to increased anticancer quinone drug sensitivity: A questionable role for the enzyme as a target for bioreductively activated anticancer drugs. Anticancer Res., 15, 1141-1146.
20. ROSE DP AND CONNOLLY JM. (1990). Effects of fatty acids and inhibitors of eicosanoid synthesis on the growth of a human breast cancer cell line in culture. Cancer Res., 50, 7139-7144.
21. SETTY BNY, GRAEBER JE AND STUART MJ. (1987). The mitogenic effect of 15- and 12-hydroxyeicosatetraenoic acids on endothelial cells may be mediated via diacylglycerol kinase inhibition. J. Biol. Chem., 262, 17613-17622.
22. 2, leukotrienes and free radicals in puromycin nephrosis in rats. Kidney Internat., 39, 920-929.
23. SIKGAL D, GIBSON NW, PREUSCH PC AND ROSS D. (1990). Metabolism of mitomycin C by DT-diaphorase: role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells. Cancer Res., 50, 7483-7489.
24. WELSCH CW. (1987). Enhancement of mammary tumorigenesis by dietary fat: review of potential mechanisms. Am. J. Clin. Nutr., 45, 192-202.